Skip to main content
  • Book
  • Open Access
  • © 2020

Ethics and Drug Resistance: Collective Responsibility for Global Public Health

  • The first book to focus on ethical issues associated with antimicrobial resistance

  • Including theoretical/conceptual approaches, in-context analysis of specific topics, and interdisciplinary perspectives

  • Authors include world-leading figures in bioethics, public health ethics, law, epidemiology, and economics

  • Critically addresses trade-offs required in response to a growing problem predicted to kill more people than cancer by 2050

  • Essential reading for scholars in bioethics and public health ethics, physicians, public health practitioners, and policy makers

Part of the book series: Public Health Ethics Analysis (PHES, volume 5)

Buying options

Softcover Book USD 49.99
Price excludes VAT (USA)
Hardcover Book USD 59.99
Price excludes VAT (USA)

Table of contents (26 chapters)

  1. Ethics, Regulation, Governance, and Drug Resistance

    1. Front Matter

      Pages 295-295
    2. Technological Fixes and Antimicrobial Resistance

      • Nicholas B. King
      Pages 309-319Open Access
    3. Tackling Anti-microbial Resistance: An Ethical Framework for Rational Antibiotic Use

      • Jasper Littmann, Annette Rid, Alena Buyx
      Pages 321-344Open Access
    4. Solidarity and Antimicrobial Resistance

      • Søren Holm, Thomas Ploug
      Pages 345-356Open Access
    5. Justifying Antibiotic Resistance Interventions: Uncertainty, Precaution and Ethics

      • Niels Nijsingh, D. G. Joakim Larsson, Karl de Fine Licht, Christian Munthe
      Pages 357-375Open Access
    6. Antimicrobial Footprints, Fairness, and Collective Harm

      • Anne Schwenkenbecher
      Pages 377-387Open Access
    7. Global Health Governance and Antimicrobial Resistance

      • Belinda Bennett, Jon Iredell
      Pages 389-399Open Access
    8. Global Governance of Anti-microbial Resistance: A Legal and Regulatory Toolkit

      • Calvin W. L. Ho, Tsung-Ling Lee
      Pages 401-420Open Access
    9. The Super-Wicked Problem of Antimicrobial Resistance

      • Jasper Littmann, A. M. Viens, Diego S. Silva
      Pages 421-443Open Access
  2. Back Matter

    Pages 445-448

About this book

This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.


  • antimicrobial resistance
  • public health ethics
  • collective responsibility
  • infectious disease
  • global health
  • hospital acquired infection
  • animal ethics
  • animal epidemiology
  • TB resistance and human rights
  • TB resistance in developing countries
  • privacy and data collection
  • ethics and AMR regulation
  • ethics of drug development
  • antibacterial drug resistance
  • infectious diseases

Editors and Affiliations

  • Monash Bioethics Centre, Monash University, Melbourne, Australia

    Euzebiusz Jamrozik, Michael Selgelid

About the editors

Doctor Euzebiusz Jamrozik is a practising physician and bioethics PhD candidate in the Monash Bioethics Centre at Monash University, where he also completed an MA in Bioethics after prior studies in medicine and philosophy at University of Western Australia. His multidisciplinary interests include infectious disease, public health ethics, and epidemiology. Among other topics, his recent publications focus on ethical implications of vaccination, vector-borne disease, human challenge studies, and climate change impact on infectious disease. He is a Fellow of the Royal Australasian College of Physicians (FRACP) and Member of the World Health Organization (WHO) Collaborating Centre for Bioethics at Monash University.

Professor Michael Selgelid is Director of the Monash Bioethics Centre and the World Health Organization (WHO) Collaborating Centre for Bioethics at Monash University in Melbourne, Australia.  His research primarily focuses on public health ethics, infectious disease ethics, research ethics, and ethical issues associated with biotechnology and other emerging technologies.  He edits a book series in Public Health Ethics Analysis for Springer and is Co-Editor of Monash Bioethics Review.  Michael earned a BS in Biomedical Engineering from Duke University and a PhD in Philosophy from the University of California, San Diego.

Bibliographic Information

  • Book Title: Ethics and Drug Resistance: Collective Responsibility for Global Public Health

  • Editors: Euzebiusz Jamrozik, Michael Selgelid

  • Series Title: Public Health Ethics Analysis

  • DOI:

  • Publisher: Springer Cham

  • eBook Packages: Religion and Philosophy, Philosophy and Religion (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s) 2020

  • License: CC BY

  • Hardcover ISBN: 978-3-030-27873-1

  • Softcover ISBN: 978-3-030-27876-2

  • eBook ISBN: 978-3-030-27874-8

  • Series ISSN: 2211-6680

  • Series E-ISSN: 2211-6699

  • Edition Number: 1

  • Number of Pages: XVII, 448

  • Number of Illustrations: 1 b/w illustrations

  • Topics: Bioethics, Medical Microbiology, Diseases

Buying options

Softcover Book USD 49.99
Price excludes VAT (USA)
Hardcover Book USD 59.99
Price excludes VAT (USA)